TGF beta expressing plasmid vector therapy (NIAID)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameTGF beta expressing plasmid vector therapy (NIAID)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionTransforming growth factor beta 1 modulators
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsAutoimmune DiseasesInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A